CD103+ tissue-resident T-cells in head and neck squamous cell carcinomas of patients treated anti-PD-1 therapy
{{output}}
Purpose: Anti-PD-1 therapy is nowadays the state of the art treatment in advanced-stage head and neck squamous cell carcinoma (HNSCC), showing improved survival rates in contrast to chemotherapy, but still lacking reliable biomar... ...
